Vitreq Bv Seggelant-Noord 2 Vierpolders Netherlands VitreQ 27G VFI Cannula-REF: CN27.D03 GTIN: 8719214221461 Recall
Check Your Product
According to the U.S. Food and Drug Administration (FDA)
Product
VitreQ 27G VFI Cannula-REF: CN27.D03 GTIN: 8719214221461
Brand
Vitreq Bv Seggelant-Noord 2 Vierpolders Netherlands
Lot Codes / Batch Numbers
All lots
Products Sold
All lots
Vitreq Bv Seggelant-Noord 2 Vierpolders Netherlands is recalling VitreQ 27G VFI Cannula-REF: CN27.D03 GTIN: 8719214221461 due to Microscopic tears of the sterile pouch may compromise sterility. Based on FDA medical device recall database.
Summary derived from FDA notice
Reason for Recall
As stated by FDA
Microscopic tears of the sterile pouch may compromise sterility
Recommended Action
Per FDA guidance
VitreQ issued Urgent Medical Device recall dated 12/16/19 letter states reason for recall, health risk and action to take: 1.Immediately examine your inventory and quarantine product from all lots subject to recall. If you have further distributed this product, please identify your customers and notify them at once of this product recall. Consider all potential users of this product in your user supply chain. You may provide a copy of this recall notification letter; 2.Complete the Attachment 1: Response Form enclosed IMMEDIATELY, as evidence of the product being returned, and we will credit your account or complete the response form even if you do not have product to return.3.Return the Attachment 1: Response Form to BVI by one of these methods: Fax 866-906-4304 or email a copy to Claims_US@bvimedical.com. If you have any specific product replacement questions you may contact Customer Service Team at: Claims_US@bvimedical.com or call 866-906-8080 from 8 A.M. to 6 P.M. EST (Monday-Friday).
Verify this information on the official source
For complete details and official instructions, check the U.S. Food and Drug Administration (FDA) directly.
View official FDA recall noticePage updated: Jan 10, 2026